MedPath

Minimal invasive Cystogastrostomy

Not Applicable
Conditions
Surgery
Registration Number
PACTR202201648766761
Lead Sponsor
Authors with no external sponsorship
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
50
Inclusion Criteria

Symptomatic cyst
Presented 6 weeks or more after the last attack of acute pancreatitis
Cysts more than 6 cm in diameter (
Located at the lesser sac < 1 cm away from the gastric wall
Well matured wall .

Exclusion Criteria

Patients with suspected true pancreatic cysts
Patients with coagulopathy or unfit for general anesthesia
Patients who did not complete the 6 months follow up period
Cysts with any previous intervention
Walled of necrosis containing > 30% of necrotic debris
Complicated cysts as abscess, intracystic bleeding and pseudo aneurysm.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Primary success rate of the procedure, which was defined as successful completion of technique plus resolution of the cyst (defined as relief of the symptoms and no residual collection more than 50% of the initial amount after 4 weeks from the procedure). Overall clinical success rate was defined as no recurrence of the collection or symptoms after 6 months even after additional procedures.
Secondary Outcome Measures
NameTimeMethod
Intraoperative data (duration of the procedure, intraoperative blood loss, gastric perforation, bowel injury) and postoperative data as hospital stay, postoperative complication (gastric ileus, hemorrhage, and surgical site infection), stent migration and mortality rate.
© Copyright 2025. All Rights Reserved by MedPath